Your gateway to experimental cancer medicine
Our network is where cutting-edge research connects with patient care. We're accelerating innovation and trial delivery across the UK.
Why choose us?
Our experimental cancer medicine centres (ECMC) network is a UK-wide collaboration of 29 specialist cancer research centres.
Through this network of 17 adult and 12 paediatric centres, we offer unrivalled early-phase expertise and industry ready infrastructure.
We enable research innovation and bring first-in-human studies to patients by connecting the UK's best clinicians with industry and regulators.
Proven expertise, measurable impact
£150m
£150m invested in the network (since launch)
981
981 clinical trials in our portfolio (2022-2025)
9,000+
over 9,000 patients recruited (2022-2025)
What we do
What we offer
We deliver early-phase trial infrastructure and expertise and streamlined access to an integrated adult and paediatric network.
What sets us apart
We provide a single entry point for feasibility and site engagement through a specialist UK-wide network, offer bespoke collaboration opportunities for industry, and maintain strong partnerships with UK regulators.
How we deliver
We have recruited over 9,000 patients between 2022 and 2025, delivered global first-in-human and first-in-Europe studies, and provide access to a diverse, all-tumour, all-age patient population.
Who we work with
Industry and partners
We are a centralised platform for commercial partners to launch trials quickly with access to expert teams, sites and processes.
Our network
Our centres have unique research strengths and work collaboratively to share data, practices, and staff training.
Patients and public
We support patient centric early-phase trials. Patient and public involvement shapes how we do this.